Cutting Edge Approach on Prodrug: Contrivance for Target Drug Delivery
- *Corresponding Author:
- Dr. Y.M. Varsha
School of Chemical and Biotechnology
SASTRA University, India
E-mail: [email protected]
Received Date: December 10, 2011; Accepted Date: December 24, 2011; Published Date: December 26, 2011
Citation: Varsha YM, Ram Mohan Rao G, Venkateswara Rao V (2011) Cutting Edge Approach on Prodrug: Contrivance for Target Drug Delivery. J Bioequiv Availab 3: 286-290. doi: 10.4172/jbb.1000100
Copyright: © 2011 Varsha YM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Drug administration procedures are very much vital and are considered to be the prime-most criteria during the drug design and its appliance. Scrutinizing this, drugs are designed in such a way, bringing some change in their persona like bioavailability and bioequivalence. One such approach called prodrug, first started in 1950’s is still a fertile area of research because of it’s insist persona. Prodrugs are the shrouded drugs which are one or two chemical or enzymatic steps away from the active parent drug. Present review delineates about the prodrug action, types of prodrugs, new prodrug therapies, nanotech allied prodrugs.